This advert is not available!
Umeå University is one of Sweden’s largest higher education institutions with over 37,000 students and about 4,700 employees. The University offers a diversity of high-quality education and world-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything is close. Our cohesive campuses make it easy to meet, work together and exchange knowledge, which promotes a dynamic and open culture.
The ongoing societal transformation and large green investments in northern Sweden create enormous opportunities and complex challenges. For Umeå University, conducting research about – and in the middle of – a society in transition is key. We also take pride in delivering education to enable regions to expand quickly and sustainably. In fact, the future is made here.
Are you interested in learning more? Read about Umeå university as a workplace
The Faculty of Medicine, which consists of 13 departments, is responsible for biomedical research and courses in the field of nursing and health care and has an extensive research and graduate education in more than 80 subjects.
Supervisor: Barbara Sixt, Department of Molecular Biology, Laboratory of Molecular Infection Medicine Sweden (MIMS), Umeå University, Sweden
Background and description of work tasks:
Almost every cell in our body has an intrinsic capacity to detect invading microbes and to respond to the threat by inducing a series of cellular defense responses. Yet, while this so-called cell-autonomous immunity may have a key role in providing protection against everyday encountered microbes, it is less effective against significant disease agents that have evolved measures to neutralize its action. Importantly, these virulence strategies also conceal the protective power of cell-autonomous immunity.
We plan to use an innovative molecular genetic approach, in combination with high-throughput screening technology, to study the impact of cell-autonomous defense responses on the intracellular growth of obligate intracellular bacterial pathogens, such as Chlamydia trachomatis. The overall goal of the project is the identification and characterization of protective defense pathways and counteracting virulence factors.
This is a pilot study (6 months) with the aim of investigating the potential of the project to be appropriate for a grant application, PhD- or post-doc project.
Its aims are to:
The selected candidate will use molecular genetic techniques to introduce mutations in human cell lines, design and carry out infection assays, and document and present the findings.
Qualifications
You must hold a University degree equivalent to a European University Master degree in molecular biology (or equivalent fields) at the time of the recruitment (240 ECTS). Qualified are also those who completed eight semesters of medical or dental program, including medical chemistry, cell and molecular biology, genetics, physiology, microbiology and independent work and those that have acquired substantially equivalent knowledge in Sweden or abroad.
You should have documented experience in molecular genetic techniques and cell culture, and an enthusiasm for host-pathogen interaction. Previous work experience with CRISPR/Cas9 technology, pathogens, and/or host response to infection is considered a strong merit. You need to be fluent in spoken and written English.
You should be highly motivated and able to work productively in a team as well as independently. Excellent communication skills for interacting effectively with senior colleagues and peers are required.
How to apply
You apply through our recruitment system. Your application must contain the following documents written in English or Swedish:
Union information is available from SACO, +46-(0)90-786 53 65, SEKO, +46-(0)90-786 52 96 and ST, +46-(0)90-786 54 31.
For questions regarding the position contact Barbara Sixt, barbara.sixt@umu.se
More about us
The Sixt lab is part of the Laboratory for Molecular Infection Medicine Sweden (MIMS) and the Umeå Centre for Microbial Research (UCMR), an interdisciplinary research center devoted to top quality research and novel applications in the field of microbiology.
You can find more information about us at www.mims.umu.se/groups/barbara-sixt; www.ucmr.umu.se, and www.molbiol.umu.se/english.
Type of employment | Special fixed-term employment |
---|---|
Employment expires | 2019-03-31 |
Contract type | Full time |
First day of employment | 2018-09-01 |
Salary | Monthly salary |
Number of positions | 1 |
Full-time equivalent | 100% |
City | Umeå |
County | Västerbottens län |
Country | Sweden |
Reference number | AN 2.2.1-1267-18 |
Contact |
|
Union representative |
|
Published | 29.Jun.2018 |
Last application date | 31.Jul.2018 11:59 PM CEST |